Length of intensive phase treatment for MDR-TB patients
The updated 2011 guidelines recommend patients with MDR-TB are recommended receive an intensive phase of treatment lasting for at least 8 months' duration. Patients who have not been treated with second-line drugs for tuberculosis in the past should undergo 20 months of treatment.
The recommended minimum duration of treatment with injectable drugs has been extended by 2 months from the previous guidelines as evidence shows that this increases the likelihood of treatment success.
What is the average duration of intensive phase treatment of MDR-TB patients in your setting? Which policy does your programme follow?
It would be good to hear your experience,
All the best,
Guidelines for Programmatic Management of Drug Resistant TB, 2011 updates (external URL)
Link leads to: http://whqlibdoc.who.int/publications/2011/9789241501583_eng.pdf
Summary: Dear colleagues,
I hope you are doing fine. Just to make sure we all have a copy of the GRADE-ed update for programmatic management of drug resistant TB, I am resending the link to these guidelines.
The 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) method was used to review the evidence and formulate recommendations.
Source: World Health Organization - WHO
Publication Date: January 1, 2011
Keywords: drug resistant, Guidelines, programmatic managementPreview